
APHMtargetrials
226 posts

APHMtargetrials
@APHMtargetrials
Essais bioguidés à l'AP-HM
Katılım Şubat 2013
37 Takip Edilen80 Takipçiler
APHMtargetrials retweetledi

we are looking for an enthusiastic oncology PhD student to join us @MCRCnews @TheChristieNHS. Our project will use circulating biomarkers and radiomics in LA-NSCLC patients before, during, and following radical CTRT to individualise care. Get in touch!
findaphd.com/phds/project/m…
English
APHMtargetrials retweetledi

Découvrez le programme définitif 1ère « Rencontre 2019 Phases Précoces en Cancérologie » :+40 intervenants pour faire de la France le pays le plus attractif pour les Phases Précoces en cancérologie. Venez nombreux !
phases-precoces.fr
#phasesprécoces #research #cancer
Français
APHMtargetrials retweetledi

Join us on Nov 22 in Paris to debate on early phases trials @aphm_actu @APHMphaseIonco @Institut_cancer @drcmassard @jeanyvesblay @AItalianoMD @univamu
Stéphane Loze@stephane_loze
Découvrez le programme définitif 1ère « Rencontre 2019 Phases Précoces en Cancérologie » :+40 intervenants pour faire de la France le pays le plus attractif pour les Phases Précoces en cancérologie. Venez nombreux ! phases-precoces.fr #phasesprécoces #research #cancer
English

Results highlight difficulties in targeting MET by a collaborative effort of French centers supported by @Institut_cancer @GroupeUNICANCER @aphm_actu @univamu
denis Moro-Sibilot@DMSLung
Crizotinib in c-MET- or ROS1-positive NSCLC: results of the AcSé phase II trial. - PubMed - NCBI ncbi.nlm.nih.gov/pubmed/31584608
English

Animal and Plant Protein Intake and Mortality ja.ma/2NF39pk in summary eat plan protein ! #Cancer #oncology #mortality #DietFoodMeals #Vegetarian
English
APHMtargetrials retweetledi

Thanks @DrewMoghanaki. Delighted and honoured to receive this prestigious @IASLC award! Jim Cox award lecture is on Monday 9th 17.05 and the award ceremony on 7th Sept 17.45 to 18.45. See you all there! @TheChristieNHS @MCRCnews #radonc
Drew Moghanaki@DrewMoghanaki
Are you a fan of @finn_corinne? If so, you might want to block your calendar for her presentation at the Monday #WCLC19 James Cox Lectureship Award. If you're really a fan, then you might want to also be aware of her 9 other presentations. #radonc library.iaslc.org/search-speaker…
English
APHMtargetrials retweetledi

Bad news for all of us #MichelPierres, world class #Immunologist, former Director of @CIML_Immunology (1991-1994), French pioneer of #AntibodyTechnology and true polymath, died last night

English
APHMtargetrials retweetledi

Cancer du poumon : Un groupe multidisciplinaire d’experts français se prononce en faveur de la mise en place rapide d’un dépistage organisé ifct.fr/index.php/fr/d… @IFCTlung @agnesbuzyn @Institut_cancer @HAS_sante #LungCancerAwarenessMonth @Mois_sans_tabac

Français
APHMtargetrials retweetledi

In #lungcancer, it is clear that we will not only be interested in #tumourcells but also in #immunecells & other factors related to the #immuneresponse @barlesi @myESMO @aphm_actu @univamu @Immunopole #ThePioneerProject latest issue of #ESMOPerspectives goo.gl/B43dPn

English
APHMtargetrials retweetledi

Les Journées de l'IFCT auront lieu les 28 &29 juin 2018. Programme et inscriptions en ligne dès à présent : ifct.fr/index.php/fr/e… @IFCTlung #lungcancer #formation

Français
APHMtargetrials retweetledi

IASLC Africa Conference on Lung Cancer 2018 . Drs. @giorgioscaglio3, @ChristianRolfo, Carbone lungcancernews.org/2018/02/19/ina…

English
APHMtargetrials retweetledi

Top paper: building on 2 recent theoretical models - the #DiscontinuityTheory & the #EquilibriumTheory - Thomas @Pradeu & #GerardEberl propose a general (and practical) #TheoryofImmunity @ImmunoConcept @institutpasteur @TrendsImmuno goo.gl/8NzxZY

English
APHMtargetrials retweetledi

#ImmunoOnc in #LungCancer #PioneerProject:
Cancer : les limites de l'immunothérapie explorées à Marseille. Article de @CDucruet pour @LesEchos #VoPqkBUwBw83EsE2.99" target="_blank" rel="nofollow noopener">lesechos.fr/industrie-serv… #immunology #cancertherapy

Français
APHMtargetrials retweetledi

Personalised medicine for nonsmall cell lung cancer by @mascaux and our team. err.ersjournals.com/content/26/146… @aphmtargetrials
English
APHMtargetrials retweetledi

Lancement d'une vaste étude sur l'immunothérapie dans le cancer du poumon sciencesetavenir.fr/sante/pioneer-… via @Sciences_Avenir
Français
APHMtargetrials retweetledi

#ImmunoOnc in #LungCancer #PioneerProject kick off meeting day 2: the team at work @univamu @aphm_actu @Inserm @CNRS @marseille @Immunopole @paoli_calmettes @CLCCLeonBerard @ClaudiusRegaud @AstraZenecaFR @HalioDx @InnatePharma #ImCheckTherapeutic

English
APHMtargetrials retweetledi

#ImmunoOnc in #LungCancer #PioneerProject: the team and the project leader @barlesi @CGI_PIAvenir @AgenceRecherche @univamu @aphm_actu @Inserm @CNRS @marseille @Immunopole @paoli_calmettes @CLCCLeonBerard @ClaudiusRegaud @AstraZenecaFR @HalioDx @InnatePharma #ImCheckTherapeutic

English

